ArticleThe Lancet. Public health2024
Nitazenes represent a growing threat to public health in Europe.
Article in The Lancet. Public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Top 10 Public Health Challenges in 2025: Lessons and Priorities for 2025-2030.Public health challenges · 2026Article
- Preclinical pharmacology of N-pyrrolidino "nitazene" opioids appearing in nonmedical drug markets.The Journal of pharmacology and experimental therapeutics · 2026Article
- Temporal and geographical patterns of nitazene detections in drug samples and biospecimens in the United States, 2019-2024.Addiction (Abingdon, England) · 2026Article
- Price of Nitazenes for Sale on Cryptomarkets and Surface Web Shops.Drug and alcohol review · 2026Article
- Monitoring of new psychoactive substances in France: update of addictovigilance data.European journal of public health · 2026Article
- US Overdose Mortality Saw First Drop Below the Jalal-Burke Exponential Growth Curve in 2024.medRxiv : the preprint server for health sciences · 2026Article
- Buprenorphine Oral Lyophilisate for Treatment of Opioid Use Disorder: Pharmacology and Clinical Efficacy.Pharmaceuticals (Basel, Switzerland) · 2026Review
- What does 'polysubstance' really mean? Comparing drug-involved deaths in CDC records vs. detailed medical examiner data from Los Angeles.The International journal on drug policy · 2026Article
- Collaborative harm reduction efforts lead to the first detection of 5-cyano isotodesnitazene in illicit street drugs.Scientific reports · 2026Article
- The nitazene epidemic in Estonia: a first report.European journal of public health · 2025Article
- The emergence of nitazenes: a new chapter in the synthetic opioid crisis.Archives of toxicology · 2025Review
- Evaluation of nitazene immunoassay test strips for rapid in-situ detection of nitazene and nitazene analogs in illicit drug samples.Harm reduction journal · 2025Article
- What Does 'Polysubstance' Really Mean? Comparing Drug-Involved Deaths in Los Angeles in CDC Records vs. Detailed Medical Examiner Data.medRxiv : the preprint server for health sciences · 2025Article
- Naloxone dosing by non-medical first-responders at opioid overdoses: findings from a qualitative interview study.Harm reduction journal · 2025Article
- Four decades of overdose prevention centres: lessons for the future from a realist review.Harm reduction journal · 2025Review
- Utilization of drug checking services in Austria: a cross-sectional online survey.Harm reduction journal · 2025Article
- Slow dissociation kinetics of fentanyls and nitazenes correlates with reduced sensitivity to naloxone reversal at the μ-opioid receptor.British journal of pharmacology · 2025Article
- The public health risks of counterfeit pills.The Lancet. Public health · 2025Article
- Characterization of novel nitazene recreational drugs: Insights into their risk potential from in vitro µ-opioid receptor assays and in vivo behavioral studies in mice.Pharmacological research · 2024Article
- In vitro structure-activity relationships and forensic case series of emerging 2-benzylbenzimidazole 'nitazene' opioids.Archives of toxicology · 2024Article
Corrections and comments
- Comment on
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
38408464What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.